Home › Funds › SB INVESTMENT ADVISERS (UK) LTD › DNA
SB INVESTMENT ADVISERS (UK) LTD position in DNA
GINKGO BIOWORKS HOLDINGS INC · Health Care
SB INVESTMENT ADVISERS (UK) LTD reported holding 610,729 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 0.08% of its reported portfolio and ranking #9 among its reported holdings. SB INVESTMENT ADVISERS (UK) LTD has disclosed DNA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SB INVESTMENT ADVISERS (UK) LTD's DNA position evolved
SB INVESTMENT ADVISERS (UK) LTD first disclosed a stake in DNA in Q3 2023 at 24,429,191 shares (US$44.2M). Across 12 filings, SB INVESTMENT ADVISERS (UK) LTD increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 610,729 shares valued at US$6.1M. Notable position changes include a 98% trim in Q3 2024 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 24.43M | $44.22M | New |
| Q4 2023 | 24.43M | $41.29M | Hold |
| Q1 2024 | 24.43M | $28.34M | Hold |
| Q2 2024 | 24.43M | $8.17M | Hold |
| Q3 2024 | 610.73K | $4.98M | Reduce |
| Q4 2024 | 610.73K | $6.00M | Hold |
| Q1 2025 | 610.73K | $3.48M | Hold |
| Q2 2025 | 610.73K | $6.87M | Hold |
| Q3 2025 | 610.73K | $8.90M | Hold |
| Q4 2025 | 610.73K | $5.08M | Hold |
| Q1 2026 | 610.73K | $3.74M | Hold |
| Q2 2026 | 610.73K | $6.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNA and 13F data
DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 32 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNA
- Anchorage Capital Group, L.L.C. 1.75M sh · $17.31M · Q2 2026
- FORBES J M & CO LLP 977.37K sh · $12.54M · Q3 2026
More on SB INVESTMENT ADVISERS (UK) LTD
FAQ
How long has SB INVESTMENT ADVISERS (UK) LTD held DNA?
SB INVESTMENT ADVISERS (UK) LTD has disclosed DNA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SB INVESTMENT ADVISERS (UK) LTD's current position in DNA?
As of Q2 2026, SB INVESTMENT ADVISERS (UK) LTD holds 610.73K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $6.05M, representing 0.08% of its reported portfolio and ranking #9.
Has SB INVESTMENT ADVISERS (UK) LTD been buying or selling DNA?
In the latest 13F filing (Q2 2026), SB INVESTMENT ADVISERS (UK) LTD held unchanged its position in DNA.
Which other funds hold DNA?
Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.